Gene Ontology annotation through association of InterPro records with GO terms

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:19834066

Altered chondrocyte differentiation and extracellular matrix homeostasis in a zebrafish model for mucolipidosis II.

Zebrafish gnptab knockdown models mucolipidosis II by reducing GlcNAc-1-phosphotransferase-dependent mannose phosphorylation.

"N-acetylglucosamine-1-phosphotransferase, the enzyme that initiates mannose 6-phosphate biosynthesis"

PMID:23733939

The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is a substrate recognition module.

GlcNAc-1-phosphotransferase alpha/beta subunits recognize lysosomal hydrolase substrates for mannose 6-phosphate tagging.

"mediates the initial step in the formation of the mannose 6-phosphate recognition signal on lysosomal acid hydrolases"

PMID:25505245

Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.

GNPTAB domains support GlcNAc-1-phosphotransferase catalytic activity and lysosomal hydrolase recognition.

"GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers"

PMID:26404503

Cathepsin-Mediated Alterations in TGFß-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting.

Loss of lysosomal targeting in MLII alters cathepsin/TGF-beta signaling and cartilage/bone development.

"Hypersecretion of acid hydrolases is a hallmark feature of mucolipidosis II (MLII)"

PMID:33055423

Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation.

Gnptab deficiency mislocalizes cathepsin activity and disrupts zebrafish heart and valve development.

"Without Gnptab, lysosomal hydrolases, including cathepsin proteases, are inappropriately secreted"

file:DANRE/gnptab/gnptab-uniprot.txt

UniProtKB entry Q5RGJ8 for Danio rerio gnptab

UniProt summarizes Gnptab as the GlcNAc-1-phosphotransferase alpha/beta precursor for lysosomal enzyme tagging.

"Catalyzes the formation of mannose 6-phosphate recognition markers on lysosomal enzymes"

file:DANRE/gnptab/gnptab-deep-research-falcon.md

Falcon deep research report on Danio rerio gnptab (UniProt Q5RGJ8)

Zebrafish gnptab (UniProt Q5RGJ8) is the catalytic alpha/beta precursor of GlcNAc-1-phosphotransferase (EC 2.7.8.17) and catalyzes the first committed step of mannose-6-phosphate biosynthesis, transferring phospho-GlcNAc from UDP-GlcNAc to the 6-hydroxyl of mannose on N-glycans of lysosomal hydrolases. Identity is directly confirmed by a structural study of a zebrafish Q5RGJ8 catalytic construct (87% identity to human GNPTAB).

"Danio rerio **gnptab** (UniProt **Q5RGJ8**) encodes the **N-acetylglucosamine-1-phosphotransferase α/β precursor** (GlcNAc-1-phosphotransferase; **EC 2.7.8.17**), the catalytic polypeptide of the mannose-6-phosphate (M6P) lysosomal enzyme-targeting pathway. This is directly verified by a peer-reviewed structural study that crystallized and biochemically characterized a **zebrafish GNPTAB minimal construct explicitly annotated as UniProt Q5RGJ8**."
The enzyme is a phosphotransferase (not a glycosyltransferase) that uses UDP-GlcNAc as the phosphate-sugar donor and requires Mg2+ or Mn2+ for activity.

"GlcNAc-1-phosphotransferase (GNPT) is a **phosphotransferase** (not a glycosyltransferase) that uses **UDP-GlcNAc** as phosphate-sugar donor; it requires **Mg2+ or Mn2+** for activity, consistent with metal coordination of phosphate groups in the active site."
The native enzyme is a heterohexamer (alpha2-beta2-gamma2): GNPTAB encodes the catalytic alpha/beta precursor that is proteolytically cleaved (after Lys928 / K928-D929) by Site-1 protease in the Golgi/TGN to generate mature alpha and beta subunits, while GNPTG encodes the auxiliary gamma subunit.

"The native GNPT enzyme is commonly described as a **heterohexamer α2β2γ2**, where: - **GNPTAB** encodes an **α/β precursor** that is **proteolytically cleaved** in the Golgi/TGN (reported at **K928–D929 / after Lys928**) to generate mature α and β subunits; cleavage is required for activity in the canonical full-length protein."
GNPTAB functions in the cis-Golgi with catalytic surfaces oriented toward the Golgi lumen, anchored by multiple transmembrane helices; localization is supported by structural topology and colocalization with the cis-Golgi marker GM130.

"GNPTAB functions in the **cis-Golgi**, with its catalytic surfaces oriented toward the **Golgi lumen**, consistent with both structural topology and colocalization evidence (GM130 marker)."
Substrate recognition of lysosomal hydrolases depends on protein-level determinants: a DMAP interaction domain in GNPTAB acts as a substrate-recognition module binding lysosomal hydrolases (cathepsin D, alpha-iduronidase) but not non-lysosomal glycoproteins, and the GNPTG gamma subunit contributes via its MRH mannose-binding domain.

"A **DMAP interaction domain** within GNPTAB serves as a **substrate-recognition module**, experimentally binding lysosomal hydrolases (cathepsin D, α-iduronidase) but not tested non-lysosomal glycoproteins."
Structural work on the zebrafish Q5RGJ8 catalytic construct mapped catalytic residues and metal coordination; mutation of Asp407 reduced activity ~500-fold and mutation of Asn1151 reduced activity ~200-fold.

"Quantitatively, mutation of **Asp407** reduced activity by ~**500-fold**, and mutation of **Asn1151** reduced activity by ~**200-fold** in the reported assays."
In zebrafish gnptab-deficient (MLII) models, reduced mannose phosphorylation of lysosomal hydrolases causes broad developmental phenotypes (craniofacial cartilage, cardiac edema, otic vesicle/otolith, pectoral fin, motility defects), rescuable by wild-type GNPTAB mRNA.

"Zebrafish gnptab depletion (morpholino-based MLII models) causes reduced mannose phosphorylation of lysosomal hydrolases and broad developmental phenotypes (craniofacial cartilage, cardiac edema, otic vesicle/otolith defects, pectoral fin defects, motility defects), with **rescue by wild-type GNPTAB mRNA**."
Loss of gnptab causes downstream cartilage/ECM pathology via dysregulated extracellular proteases: chondrocytes fail to intercalate and are ~25% larger, with sustained cathepsin and MMP activity; genetic or pharmacologic cathepsin K inhibition partially rescues cartilage defects.

"In gnptab-deficient embryos, there is increased and sustained activity of cathepsins and MMPs, regionally enriched in the head, linking lysosomal mistargeting to extracellular protease-driven cartilage pathology."